Hong Kong Stock Exchange is tightening the order price limit to five times. Find out what this means for investors starting Nov. 2.
Author: Krista T. Calloway
Krista T. Calloway is a writer and editorial contributor at ehealthycity.com, covering news and features across the site. Krista focuses on clear, reader-friendly reporting.
Vasculitis Drug Approval: Questionable Data Raises Concerns
Vasculitis drug approval data raises reliability concerns as Japan’s health ministry questions findings.
Cancer drug price cuts: India slashes prices by 70%!
Cancer drug price cuts are set to save patients up to 70% starting November 9.
Dr Reddy’s Laboratories stock: Best Proven Insights
Dr Reddy’s Laboratories stock is in focus as USFDA completes inspection at FTO-9 plant, signaling potential positive developments.
Clevidipine Injectable Emulsion: Proven Benefits for Patients
Clevidipine injectable emulsion offers proven benefits for patients and healthcare providers alike, especially following Shanghai Pharmaceuticals’ recent approv
GLP-1 obesity drug: Hanmi’s Proven Breakthrough for Weight Loss
GLP-1 obesity drug is set to launch as Hanmi Pharmaceutical’s innovative solution for weight management in South Korea.
Aurobindo Pharma acquisition: Proven strategy to boost growth
Aurobindo Pharma acquisition has been completed, enhancing its market position and growth potential in the pharmaceutical sector.
Drug Price Cap: The Worst Impact on Consumers Revealed
Drug price cap discussions highlight the worst effects on common people in India. Learn more about the Supreme Court’s proposal.
Entero Healthcare Acquisition: Proven Benefits for Investors
Entero Healthcare acquisition shows promising growth after Anand Chemiceutics deal.
European Commission Approval: Menarini and NewAmsterdam’s Breakthrough
European Commission Approval brings exciting news for Menarini and NewAmsterdam’s innovative therapies.